Tick-borne encephalitis is a viral infection caused by the tick-borne encephalitis virus (TBEV). The tick-borne encephalitis infection mainly affects small rodents, but humans are sometimes accidental hosts. Tick-borne encephalitis has an incubation period of one to two weeks, after which symptoms develop such as fever, muscle aches, headache, anorexia, nausea, and vomiting. The second phase of the disease, which only one third of infected individuals experience, occurs approximately three weeks after being bitten by the tick and affects the central nervous system, causing symptoms of encephalitis such as drowsiness, confusion, or paralysis. Symptoms of tick-borne encephalitis are more severe and dangerous in adults. Treatment of tick-borne encephalitis includes supportive care and hospitalization. To prevent tick-borne encephalitis, individuals should use insect repellents and wear protective clothing. A vaccine is available in endemic areas.
Top Research Reagents
We have 3869 products for the study of Tick-borne Encephalitis that can be applied to Flow Cytometry, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Western Blot from our catalog of antibodies and ELISA kits.
Tick-borne Encephalitis is also known as tick-borne encephalitis, siberian tick-borne encephalitis, western european tick-borne encephalitis, encephalitis, russian spring-summer, russian spring-summer encephalitis, encephalitis, central european, central european encephalitis, west-siberian encephalitis, encephalitis tick-borne, taiga encephalitis, far eastern tbe, encephalitis.